Key result
Surgical management of transfemoral TAVI access is linked to ~4% 30-day mortality and no vascular deaths.
Why the study?
TAVI is associated with substantial rates of vascular complications, and the surgical management of percutaneous transfemoral access by vascular surgeons requires description and outcome reporting.
Does surgical management of percutaneous transfemoral access by a vascular surgeon minimize vascular complications in patients undergoing TAVI?
Cohort (n=220)
Does surgical management of percutaneous transfemoral access by a vascular surgeon minimize vascular complications in patients undergoing TAVI?
A multidisciplinary approach involving vascular surgeons for managing percutaneous transfemoral access during TAVI is associated with low rates of vascular complication-related mortality.
Vascular surgeon-led femoral access management in TAVI yielded low major complications and no vascular deaths; leaves open whether routine involvement reduces events versus standard care.
Transcatheter aortic valve implantation (TAVI) is associated with substantial rates of vascular complications. The aim of our study is to describe the surgical management of percutaneous transfemoral access by a vascular surgeon and to report the 30-day postoperative vascular complications and mortality. Perioperative procedures to manage the femoral access site were recorded retrospectively from 220 consecutive patients who underwent TAVI. Postoperative vascular complications related to the main access were categorized according to the Valve Academic Research Consortium 2 classification. Perioperative procedures related to vascular access were performed for 56 (25.4%) patients: 6 patients required open surgical repair, 48 patients underwent endovascular stenting, and 2 patients had both procedures. The all-cause mortality was 3.6%, but no death related to a vascular complication was reported during the 30-day postoperative follow-up period. Ten (4.5%) patients developed postoperative hematomas; 2 (0.9%) of them were retroperitoneal and led to major bleeding requiring an unplanned surgical intervention. Our study underlines the utility of a multidisciplinary approach to manage the percutaneous access in TAVI for managing postoperative vascular complications.
No takes yet. Share an insight, caveat, or question.
Lareyre et al. (2017) conducted a cohort in Transcatheter aortic valve implantation (TAVI) (n=220). Surgical management of percutaneous transfemoral access was evaluated on 30-day postoperative vascular complications and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: